On December 4, 2015, the Food and Drug Administration (FDA) released a drug safety communication after a safety review resulted in adding warnings to the labels of a class of Type 2 diabetes drugs called sodium glucose cotransporter-2 inhibitors or SGLT2 inhibitors, like Johnson & Johnson’s Invokana.
The agency revised the labels to include risks of too much acid in the blood and serious urinary tract infections (UTIs). Both conditions may lead to hospitalization. SGLT2 inhibitors release blood sugar via the urine and reduce blood glucose levels. However, this increases the risk of diabetic ketoacidosis (DKA), a life-threatening condition in which the body produces high levels of blood acids called ketones.
DKA occurs when the body cannot break down sugar as an energy source. Instead, the body burns fat for energy, producing ketones. Ketones are waste products and poison the body. DKA can cause diabetic coma, even death. The FDA warns, “Patients should stop taking their SGLT2 inhibitors and seek medical attention immediately if they have any symptoms of ketoacidosis.” Symptoms include nausea, vomiting, trouble breathing, confusion, abdominal pain, and fatigue. DKA associated with the use of SGLT2 inhibitors can occur with normal blood glucose levels. Consequently, this may delay treatment of the ketoacidosis because the blood glucose levels were below those typically expected for diabetic ketoacidosis.
SGLT2 inhibitors, such as Invokana, may cause urinary tract infections or bladder infections. The signs and symptoms of a UTI include painful urination, burning sensation in the urethra, frequent urination or urge to urinate, blood in the urine, fever, and flank pain (pain in the lower stomach or pelvis). Symptoms in the elderly can be vague or non-specific.
Healthcare professionals should monitor patients taking SGLT2 inhibitors who present with suggestive symptoms for ketoacidosis and urinary tract infections.
If you suffered diabetic ketoacidosis (DKA) or a urinary tract infection (UTI) after taking Invokana, contact an attorney at Kershaw, Cook & Talley for a free case evaluation at 888-997-5170.
The attorneys at Kershaw, Cook & Talley successfully represent consumers in lawsuits against manufacturers and companies involving defective products and product recalls. Our experienced trial attorneys recover thousands of dollars on behalf of injured individuals in cases involving defective medical devices, dangerous drugs, car defects and more.
At times, attorneys require further expertise and resources, legally and financially, to resolve a legal matter. We have the team, capability and dedication to handle challenging cases. If you have a case exceeding your resources with respect to workforce or experience, consider contacting our firm. We welcome referrals from firms in Sacramento and throughout the United States.
We provide free case consultations. If you, or a loved one, suffered an injury due to another’s negligence or wrongful conduct, call our firm. We will examine your individual situation and explain your legal rights. Our attorneys have extensive experience representing injured individuals, in both jury trials and settlement negotiations.
Kershaw, Cook & Talley is a Sacramento law firm founded on the principle of helping our clients through personalized legal services. With this philosophy, Kershaw, Cook & Talley has garnered a statewide and national reputation for providing outstanding legal representation and obtaining significant compensation for our clients.
We understand personal injury cases are often emotionally and financially straining. Our team of top personal injury attorneys in Sacramento is committed to seeking justice for individuals injured as a result of another's negligence or intentional misconduct. At Kershaw, Cook & Talley, our experienced personal injury attorneys will hold the responsible parties accountable for their actions.